Interestingly, there have been some case reports of individuals with PCSK9 loss-of-function (LOF) mutations that were associated with liver steatosis in the context of obesity and type 2 diabetes71,72; however, individuals with LOF and hypocholesteremia do not exhibit excessive liver fat accumulation73. Here, PCSK9 is linked to Hepatic steatosis.